KZA 0.00% 8.0¢ kazia therapeutics limited

News: Novogen proves cancer drug works

  1. lightbulb Created with Sketch. 1
    .

    Novogen Limted (ASX:NRT) says that it has key data proving its experimental anti-cancer drug Cantrixil is highly effective at killing ovarian cancer cells.
     
    In a presentation by Yale medical professor Gil Mor in San Franciso, Novogen says its researchers have proved the drugs ability to wipe out the tumour initiating cells where other standard treatment drugs failed. 
     
    The active ingredient of Cantrixil is uniquely able to target chemo-resistant cancer stem cells. 
     
    The experimental treatment will begin its first in-human studies later this year, targeted at late stage ovarian and colo-rectal cancer. 
     
    Novogen made a net loss of $2.4 million for the first six months of the 2015 financial year. 
     
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.